Non Cardioembolic Ischemic Stroke clinical trials

Explore recruiting non cardioembolic ischemic stroke clinical trials.

Recruiting non cardioembolic ischemic stroke studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Cardioembolic Ischemic Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (TAILOR trial)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

(20604 OCEANIC STROKE) A multicenter, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the prevention of ischemic stroke in male and female participants aged 18 years and older after an acute non-cardioembolic ischemic stroke or high-risk TIA

Slovakia, Latvia, Hungary, Sweden, Netherlands, Austria +14 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study to learn about the amount of asundexian in the blood when healthy participants take different types of asundexian tablets

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Non Cardioembolic Ischemic Stroke trials by city

Non Cardioembolic Ischemic Stroke in Toronto Non Cardioembolic Ischemic Stroke in Vancouver Non Cardioembolic Ischemic Stroke in Montreal Non Cardioembolic Ischemic Stroke in Calgary Non Cardioembolic Ischemic Stroke in Edmonton Non Cardioembolic Ischemic Stroke in Ottawa Non Cardioembolic Ischemic Stroke in Winnipeg Non Cardioembolic Ischemic Stroke in Quebec City Non Cardioembolic Ischemic Stroke in Hamilton Non Cardioembolic Ischemic Stroke in Kitchener Non Cardioembolic Ischemic Stroke in London Non Cardioembolic Ischemic Stroke in Halifax Non Cardioembolic Ischemic Stroke in New York Non Cardioembolic Ischemic Stroke in Los Angeles Non Cardioembolic Ischemic Stroke in Chicago Non Cardioembolic Ischemic Stroke in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease